Atopic Dermatitis clinical trials at UCSF
2 in progress, 0 open to new patients
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Sorry, not currently recruiting here
This 4-week study will evaluate the safety, pharmacokinetics (PK), and efficacy of crisaborole ointment 2%, applied twice daily (BID) in subjects who are 3 months to less than 24 months of age with mild-to-moderate AD.
San Francisco, California and other locations
Sorry, not yet accepting patients
This is a single-arm, open-label study, which will examine the effect of dupilumab on the immunologic and genetic environment within atopic dermatitis lesions.
San Francisco, California